Netta Blondheim-Shraga
Chief Tech/Sci/R&D Officer en BRAINSTORM CELL THERAPEUTICS INC. .
Perfil
Netta Blondheim-Shraga is currently the Vice President-Research & Development at Brainstorm Cell Therapeutics, Inc. She previously worked as a Study Director at Crown Bioscience, Inc. from 2019 to 2020.
Dr. Blondheim-Shraga has a graduate degree from Tel-Aviv University, an undergraduate degree from The Hebrew University of Jerusalem, and a doctorate from Bar-Ilan University and the Faculty of Medicine.
Cargos activos de Netta Blondheim-Shraga
| Empresas | Cargo | Inicio |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 12/05/2022 |
Antiguos cargos conocidos de Netta Blondheim-Shraga.
| Empresas | Cargo | Fin |
|---|---|---|
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | 01/09/2020 |
Formación de Netta Blondheim-Shraga.
| Tel-Aviv University | Graduate Degree |
| The Hebrew University of Jerusalem | Undergraduate Degree |
| Bar-Ilan University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Netta Blondheim-Shraga
